BioAegis Therapeutics
PrivateLast Round
Grant
Oct 16, 2023
Total Funding Raised
$50M
Company Overview
BioAegis Therapeutics is a clinical-stage biotechnology company developing therapies for inflammatory, infectious, and degenerative diseases based on its plasma gelsolin (pGSN) platform.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery, Precision Medicine
Business Model
B2G
Customer Profile
Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
BioAegis Therapeutics Comparables
Compare BioAegis Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Aqualung Therapeutics Corporation | 82% | |
| Implicit Bioscience | 78% | |
| Trove Therapeutics | 77% | |
BioAegis Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Oct 16, 2023 | ||||
| Series C | Mar 22, 2022 | ||||
| Convertible Debt | Jun 23, 2020 | ||||
| Debt | Apr 28, 2020 | ||||
| VC Round | Sep 17, 2018 | ||||
Seed | Feb 8, 2013 |
BioAegis Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Public Health Emergency Medical Countermeasures Enterprise | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 21, 2026
Monthly visitors grew 95% MoM, reaching 1.3K.
- May 2, 2025
Monthly visitors increased 45% MoM, reaching 1.4K.
BioAegis Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about BioAegis Therapeutics's valuation, stock price, and market status.